Merus Labs International Inc. (TSE:MSL – Get Free Report) (NASDAQ:MSLI)’s stock price crossed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of C$0.00 and traded as high as C$1.65. Merus Labs International shares last traded at C$1.65, with a volume of 21,975 shares changing hands.
Merus Labs International Stock Performance
The company’s 50-day moving average price is C$1.65.
About Merus Labs International
Merus Labs International Inc is a specialty pharmaceutical company. The Company is engaged in the acquisition and licensing of branded prescription pharmaceutical products. The Company’s products include Elantan, Isoket, Deponit, Sintrom, Emselex/Enablex, Surgestone, Provames, Speciafoldine, Tredemine, Salagen, Estraderm MX and Vancocin.
Read More
- Five stocks we like better than Merus Labs International
- How to Plot Fibonacci Price Inflection Levels
- Is Monolithic Power Systems a Screaming Buy After Near 40% Drop?
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Applied Materials Market Capitulates: Now is the Time to Buy
- What is a Stock Market Index and How Do You Use Them?
- 3 Ultra-High Dividend Yield Stocks for the New Year
Receive News & Ratings for Merus Labs International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merus Labs International and related companies with MarketBeat.com's FREE daily email newsletter.
